Fortress Biotech (FBIO) Research & Development (2010 - 2026)
Fortress Biotech's Research & Development came in at $805,000 for Q2 2026, down 90.1% from $8.13 million a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Fortress Biotech reported Research & Development of $8.77 million, down 71.9% year-over-year; for FY2025, it came in at $11.9 million, down 79.0% from FY2024.
- Research & Development has declined in each of the last three years, with a five-year compound annual growth rate of -28.6% (FY2020 to FY2025).
- Going back by year, Research & Development was $56.63 million in FY2024 (-44.3%), $101.75 million in FY2023 (-24.6%), $134.88 million in FY2022 (+4.7%) and $128.87 million in FY2021 (+101.0%).
- The five-year range for quarterly Research & Development is -$367,000 (Q4 2025) to $43.05 million (Q4 2021).
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 139.7%), and the weakest in Q3 2025 (a decline of 97.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Fortress Biotech | 72.28 Mn | -322.33 Mn | 12.58 Mn | 805,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 805,000.00 |
| Dec 31, 2025 | -367,000.00 |
| Sep 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 8.13 Mn |
| Mar 31, 2025 | 3.94 Mn |
| Dec 31, 2024 | 9.69 Mn |
| Sep 30, 2024 | 9.45 Mn |
| Jun 30, 2024 | 12.67 Mn |
| Mar 31, 2024 | 24.84 Mn |
| Dec 31, 2023 | 9.75 Mn |
| Sep 30, 2023 | 20.35 Mn |
| Jun 30, 2023 | 32.14 Mn |
| Mar 31, 2023 | 39.51 Mn |
| Dec 31, 2022 | 35.12 Mn |
| Sep 30, 2022 | 29.90 Mn |
| Jun 30, 2022 | 33.13 Mn |
| Mar 31, 2022 | 36.72 Mn |
| Dec 31, 2021 | 43.05 Mn |
| Sep 30, 2021 | 28.08 Mn |
| Jun 30, 2021 | 33.83 Mn |
API Access
Fortress Biotech Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();